ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
31.00
-0.50
(-1.59%)
Cerrado 30 Marzo 9:30AM
Gráfico avanzado
Rendering Error

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
31.00
Postura de Compra
30.86
Postura de Venta
31.20
Volume Operado de la Acción
1,441,911
29.41 Rango del Día 31.15
27.72 Rango de 52 semanas 50.54
Capitalización de Mercado [m]
Precio Anterior
31.50
Precio de Apertura
30.40
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
655,356
Acciones en circulación
249,588,059
Rendimiento del Dividendo
3.90%
Ratio Precio/Utilidad
15.26
Beneficio por acción (BPA)
2.03
turnover
2.86B
Beneficio neto
507M

Acerca de Edenred SE

Sector
Security,commodity Exchanges
Industria
Security,commodity Exchanges
Sitio web
Sede
Issy-les-moulineaux, Hauts-de-seine, Fra
Fundado
-
Edenred SE is listed in the Security,commodity Exchanges sector of the Euronext with ticker EDEN. The last closing price for Edenred was 31.50 €. Over the last year, Edenred shares have traded in a share price range of 27.72 € to 50.54 €.

Edenred currently has 249,588,059 shares in issue. The market capitalisation of Edenred is 7.86 € billion. Edenred has a price to earnings ratio (PE ratio) of 15.26.

EDEN Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.63-1.9917799557431.6331.929.4153351731.34653732DE
40.812.6830076184230.1934.9329.4171778832.41542918DE
12-0.16-0.51347881899931.1634.9329.4165535631.97575466DE
26-4.86-13.552704963735.863627.7273435931.38857209DE
52-18.23-37.030266097949.2350.5427.7268957136.15921629DE
156-13.8-30.803571428644.862.427.7255901145.61733426DE
260-6.92-18.248945147737.9262.427.7251820144.70158465DE

EDEN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Edenred?
El precio actual de las acciones de Edenred es 31.00 €
¿Cuántas acciones de Edenred están en circulación?
Edenred tiene 249,588,059 acciones en circulación
¿Cuál es la capitalización de mercado de Edenred?
La capitalización de mercado de Edenred es EUR 7.86B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Edenred?
Edenred ha negociado en un rango de 27.72 € a 50.54 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Edenred?
El ratio precio/beneficio de Edenred es 15.26
¿Cuál es el ratio de efectivo a ventas de Edenred?
El ratio de efectivo a ventas de Edenred es 2.71
¿Cuál es la moneda de reporte de Edenred?
Edenred presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Edenred?
El último ingresos anual de Edenred es EUR 2.86B
¿Cuál es el último beneficio anual de Edenred?
El último beneficio anual de Edenred es EUR 507M
¿Cuál es la dirección registrada de Edenred?
La dirección registrada de Edenred es 14-16, BOULEVARD GARIBALDI, ISSY-LES-MOULINEAUX, HAUTS-DE-SEINE, 92130
¿Cuál es la dirección del sitio web de Edenred?
La dirección del sitio web de Edenred es www.edenred.com
¿En qué sector industrial opera Edenred?
Edenred opera en el sector SECURITY,COMMODITY EXCHANGES

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALSRSSirius Media
0.0108 €
(42.11%)
36.98M
DBVDBV Technologies
1.08 €
(38.28%)
10.56M
ABOABO Group Environment NV
5.30 €
(24.41%)
54.94k
MLOCTOctopus Biosafety
0.13 €
(17.12%)
11.6k
MLIMLImalliance
0.30 €
(15.38%)
310
ALCYBCybergun
0.0002 €
(-33.33%)
256.04M
ALALOAcheterLouerFR
0.0018 €
(-33.33%)
324M
TDBSTonner Drones
0.0044 €
(-16.98%)
818.54k
MLIDSIds
0.30 €
(-14.29%)
1.23k
ALVERVergnet
0.0007 €
(-12.50%)
499.93M
ALVERVergnet
0.0007 €
(-12.50%)
499.93M
ALALOAcheterLouerFR
0.0018 €
(-33.33%)
324M
ATOAtos SE
0.004 €
(-2.44%)
316.86M
ALCYBCybergun
0.0002 €
(-33.33%)
256.04M
ALEUPEuroplasma
0.0149 €
(1.36%)
101.8M

EDEN Finanzas

Finanzas
Rendering Error
GetSeriousOK GetSeriousOK 5 minutos hace
What's you prediction for FY Gross Revenues?

I predict $500,000

3331 is predicting $1,600,000

Previous two years they did about $700,000

They started selling to the veterinarians and the VA and the Taiwan distributors in 2024 so that could
BIEL
WooptdooU WooptdooU 6 minutos hace
The interviewer noted the SILENCE on the insider buys question. Don't forget that. It is VERY TELLING and IMPORTANT at this point. Insiders don't appear to believe. That is a poor showing. That's why I would rather wait and pay higher than xontinue to catch the falling knife. It is painful, that's f
LWLG
santafe2 santafe2 6 minutos hace
Even a fool like DJT can hear it when his base is put off by a billionaire who says that if grandma is 'real America' she won't mind missing her social security check. They told Face The Nation that Lutnick would not be available for comments on tariffs...:).
DJT
louieforpar louieforpar 7 minutos hace
I think he'll be dead in less than four one way or another
XMaster2023 XMaster2023 8 minutos hace
Investor082- I have asked you your credentials as a basis for evaluating the success of the trial for DCVax-L of which there were 73 coauthors. Of which you have not replied. Below please find one of the coauthors who you say is wrong.

Jian L. Campian, M.D., Ph.D., is a Medical Neuro-
NWBO
XMaster2023 XMaster2023 8 minutos hace
Investor082- I have asked you your credentials as a basis for evaluating the success of the trial for DCVax-L of which there were 73 coauthors. Of which you have not replied. Below please find one of the coauthors who you say is wrong.

Jian L. Campian, M.D., Ph.D., is a Medical Neuro-
NWBO
boywonder1 boywonder1 8 minutos hace
You have been reported for buying at your imaginary 0.0001,lol. What a fool you are. Thank you for all documentation as you make it too easy. Everyone report this stock price manipulator, it is a crime‼️ Your angry 2 inch will not be needed where you are going. Bend over .. roasted. Love it. $$$$Rit
RITE
Smitty5150 Smitty5150 9 minutos hace
Anavexs' lead compound, Anavex 2-73, will be taken as a prophylactic. Funny thing is, there other compound, A 3-71, is supposed to have even better efficacy. I think they are about to intimate a trial with 3-71 for schizophrenia. If it pans out in the EU with 2-73 form Alz...a run to $100 is not out
NWBO
ombowstring ombowstring 9 minutos hace
Very true - and the "US corporations raking in endless billions from the sale of the weapons used" are paid by the U.S. government, much of it borrowed money.

I just watched this - Hitler: From Homeless to Monster - on YouTube. It gives a good synopsis of the life of the most brutal m
RKT989 RKT989 9 minutos hace
Sooo...How many times are PSC's Signed WITHOUT DRILLING IN THE BLOCK IN QUESTION...such as block 4.
ERHE
jbog jbog 10 minutos hace
I don't think anyone knows how the tariff environment will "shake-out", but steel will always be needed. If the share price drifts lower it begins to look overdone.

The American Companies raised the price of HRC 27% as the Tariffs were mentioned. That means they want the money instea
WooptdooU WooptdooU 10 minutos hace
Pp bot? You only post like a kid against another post. Keep it up, and you will be on "IGNORE", Hahahaha.
LWLG
XMaster2023 XMaster2023 10 minutos hace
The only one not telling the truth is you my friend, because you are paid not to tell the truth.
NWBO
Thomas@yahoo Thomas@yahoo 11 minutos hace
CC12 We are also now in 14 locations of Better Health Market as well as all the others I’ve already posted. I hope to have some other GREAT NEWS COMING SOON…
CVSI
Investor082 Investor082 11 minutos hace
He is LG’s buddy. What do you expect?
NWBO
Investor082 Investor082 12 minutos hace
No one is disputing JAMA publication, but that does not give LG and LP freedom to lie to shareholders.

Let’s see how Flip sees LG’s lying behavior.
NWBO
Investor082 Investor082 15 minutos hace
If LP ever said that they are not filing to FDA because of Flaskworks and volume consideration then she gets slapped with a lawsuit earlier than Q4 2025!

The reason they are not filing with FDA is that FDA will simply reject their application due to lack of specificity with patient l
NWBO
srinsocal srinsocal 15 minutos hace
Your declaration was, " Then who had the 65 million shares on the ASK at .0002 all day," Wrong.

Must not have read the info on how MMs operate, here it is again.


I am sure you are aware that on the OTC Traders Buy from the MMs at the 'Ask price' and Sell to the
BIEL
Smitty5150 Smitty5150 16 minutos hace
your deceiving people with your statements. Whatever the flavor of the day, in regards to the current NWBO topic, you "have a friend". CEOs of Biotechs, Rearchers, Doctors, and now, in your latest post, a high-end financials guy. In your latest, your friend that in the financial services industry -
NWBO
Steady_T Steady_T 17 minutos hace
Don't speak for everyone else. Speak for yourself. I'll chose what I think is legit about NWBO for myself.

Your argument is not fact based but rhetorical and as such has little value, at least to me. Others might find your sweeping claims worth consideration.

And except
NWBO
SPANISH_gladiator SPANISH_gladiator 18 minutos hace
And could be some debtors who was paid in common shares?????? it is so weird that any of theese one does post in this board. They know some thing ? i bet for thinking that yes.
RMTD
Eagle1 Eagle1 18 minutos hace
HI Janice Homebrew et all. Just checking in here to say hi and hope all is well.
XMaster2023 XMaster2023 18 minutos hace
Investor082- I have asked you your credentials as a basis for evaluating the success of the trial for DCVax-L of which there were 73 coauthors. Of which you have not replied. Below please find one of the coauthors who you say is wrong.
Dr. Iwamoto is a neuro-oncologist whose previous train
NWBO
PegnVA PegnVA 19 minutos hace
The price we pay for American descent into fascism.....
Philosophy professor Jason Stanley, as well as historians Timothy Snyder and Marci Shore have decided to leave Yale University and move to Canada. Starting in the fall of 2025, they will work at the University of Toronto and teach at the

Su Consulta Reciente

Delayed Upgrade Clock